💙 🔷 Not impressed by Big Tech in Q3? Explore these Blue Chip Bargains insteadUnlock them all

Paragon Fine and Speciality Chemical's IPO sees 33 times oversubscription

EditorRachael Rajan
Published 2023-10-27, 10:16 a/m
© Reuters.

Paragon Fine and Speciality Chemical's initial public offering (IPO) was oversubscribed by 33 times on its second day. The company, which specializes in the production of chemicals for various industries including cosmetics, pharma, agrochemicals, pigments and dyes, saw investors acquiring 12.63 crore shares against an offer of 36.96 lakh shares.

The Rs 51.66-crore public issue was subscribed by 11.07 times on the first day. Retail participants, high networth individuals, and Qualified Institutional Buyers (QIB) subscribed 48.4, 39.3, and 14.63 times their respective quotas.

The IPO only includes a fresh issue by the company and is set to close on October 30th. The net proceeds from the IPO will be used for various purposes such as factory construction and machinery expansion at their Ahmedabad facility. Additionally, a portion of the funds will be allocated for debt reduction by Rs 12.90 crore and Rs 13 crore for working capital requirements.

Anchor investors have shown significant interest in the IPO with Morgan Stanley (NYSE:MS), MAIQ Growth Scheme, Nova Global Opportunities Fund, LC Radiance Fund VCC, and Finavenue Growth Fund investing Rs 14.7 crore in the total issue.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.